510(k) Report

510(k) · Cleared

Recalled · Class II · 2012

Biosign Flu a+B

K083746510(k) TraditionalCleared Nov 10, 2010693-day reviewClass II21 CFR 866.3328Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Princeton BioMeditech Corp. · PSZ Devices Detecting Influenza A, B, And C Virus Antigens

Cleared on Nov 10, 2010 as substantially equivalent to K053146 (Quidel Corp., 2005) after a 693-day review. Its family tree reaches back 5 generations to 1990. It has been recalled 3 times.

Decided
Nov 10, 2010
Review
693 days
Class
Class II
Product code
PSZ
Recalls
3
Predicates
1

Its longest line of descent runs back 5 generations to K902609 (1990). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
  2. 4 generations backK981651 AB Flu OiaBiostar, Inc. · 1998
  3. 3 generations backK023556 Flu Oia a/B Test KitThermo Biostar, Inc. · 2003 · Recalled
  4. 2 generations backK031899 Quickvue Influenza a+B TestQuidel Corp. · 2003
  5. 1 generation backK053146 Quickvue Influenza a + B TestQuidel Corp. · 2005
  6. This deviceK083746 Biosign Flu a+BPrinceton BioMeditech Corp. · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K902609Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic1990—
−4K981651AB Flu OiaBiostar, Inc.1998—
−3K023556Flu Oia a/B Test KitThermo Biostar, Inc.20031
−2K031899Quickvue Influenza a+B TestQuidel Corp.2003—
−1K053146Quickvue Influenza a + B TestQuidel Corp.2005—
0 (this device)K083746Biosign Flu a+BPrinceton BioMeditech Corp.2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
FIG. 1 — Lineage of K083746, 1990–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PSZ device

  1. #1 K252283 Nano-Check Influenza A+B Testscore 14.9 · 15 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K053146Quickvue Influenza a + B Test
Summary page 1
…Name: Influenza virus serological reagents (2I1CFR 866.3330) 4. Identification of legally marketed devices to which claims of equivalence are made: K053 146: QuickVue Influenza A+B Test by Quidel Corp. 5. Device Description: RioSign® Flu A±B is an immuno-chromatographic test for…
Quidel Corp.2005—

Also cleared against K053146: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 9, 2012Class IIZ-2306-2012Nonconforming Material/ComponentThere have been reports of dual positive (Flu A + Flu B positive) results being encountered.
Mar 9, 2012Class IIZ-2308-2012Nonconforming Material/ComponentThere have been reports of dual positive (Flu A + Flu B positive) results being encountered.
Mar 9, 2012Class IIZ-2307-2012Nonconforming Material/ComponentThere have been reports of dual positive (Flu A + Flu B positive) results being encountered.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 5 companies; a new generation was cleared every 4.3 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • 5 other devices also cite its predicate K053146.

How does its category compare?

All PSZ devices

PSZ Devices Detecting Influenza A, B, And C Virus Antigens: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · PSZ

2in 2025

2007: 22008: 12009: 72010: 52011: 32012: 22013: 82014: 12015: 42016: 32017: 32018: 52020: 22023: 22025: 22026 (partial year): 2
2007high 8 (2013) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSZ

28in 2018

2009: 20 days median2010: 29 days median2011: 80 days median2013: 28 days median2015: 27 days median2016: 29 days median2017: 200 days median2018: 28 days median
2007high 200 (2017) · low 20 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PSZ

1in 2022

2020: 12022: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PSZ

60in 2025

2018: 12019: 12020: 52021: 422022: 102023: 122024: 162025: 60
2007high 60 (2025) · low 0 (2007)2025

MAUDE reports naming product code PSZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
200972000
201052900
201138000
20122—00
201382800
20141—00
201542700
201632900
2017320000
201852801
20190—01
20202—15
20210—042
20220—110
20232—012
20240—016
20252—060
20262—0—

What is it indicated for?

The BioSign®~ Flu A+B test is an in vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab, nasopharyngeal aspirate/wash specimens of patients with signs and symptoms of respiratory infection. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. A negative test result is presumptive and it is recommended these results be confirmed by viral culture. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decisions. The test is intended for professional and laboratory use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K083746: Biosign Flu a+B.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K083746

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026